Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

NCT03649945 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Docetaxel
DRUG: Nedaplatin
DRUG: Endostar

Sponsor

First Affiliated Hospital of Guangxi Medical University